CurifyLabs
Helsinki, Finland
◆ Total Raised
$14M
◆ Stage
series-a
◆ Location
Helsinki, Finland
◆ Founded
2021
◆ Team size
11-50
◆ Links
◆ About CurifyLabs
A Finnish startup using 3D printing technology for medicine compounding.
◆ What sets it apart
CurifyLabs is the first company in the world to offer 3D printing of medicine as a scalable, practical technology using GMP-manufactured printable pharmaceutical inks.
◆ Sectors
◆ Business
Modelhardware
CustomerPharmacies, hospitals, and veterinary facilities
◆ Notable
- Closed a €12 million funding round
- Launched the first-ever GMP-manufactured printable pharmaceutical inks
- Released the PharmaPrinter Aurum for pharmaceutical compounding
- Partnered with APL (Sweden) to deliver 3D-printed medicines to the Swedish market by 2025
◆ Backing funds on Raise
- Lifeline Venturesseries-a
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does CurifyLabs do?
A Finnish startup using 3D printing technology for medicine compounding.
Where is CurifyLabs based?
CurifyLabs is based in Helsinki, Finland, founded in 2021.
How much has CurifyLabs raised?
CurifyLabs has raised $14M in tracked funding and is currently at the series-a stage.
Who has invested in CurifyLabs?
Investors in CurifyLabs include Lifeline Ventures.